Skip to main content
Top
Published in: Italian Journal of Pediatrics 1/2014

Open Access 01-12-2014 | Case report

Severe congenital neutropenia due to G6PC3 deficiency: early and delayed phenotype in two patients with two novel mutations

Authors: Lucia Dora Notarangelo, Gianfranco Savoldi, Sara Cavagnini, Veronica Bennato, Sabrina Vasile, Alba Pilotta, Alessandro Plebani, Fulvio Porta

Published in: Italian Journal of Pediatrics | Issue 1/2014

Login to get access

Abstract

Severe Congenital Neutropenia type 4 (SCN4, OMIM 612541) is a rare autosomal recessive disease due to mutations in the G6PC3 gene. The phenotype comprises neutropenia of variable severity and other anomalies including congenital heart defects, prominent superficial veins, uro-genital anomalies, facial dysmorphism, growth and developmental delay and intermittent thrombocytopenia. In some patients, SCN represents the only manifestation of the disease. Variable findings have been reported at bone marrow examination ranging from a maturation arrest at the myelocyte/promyelocyte stage (either in a hypocellular or hypercellular context) to myelokathexis. Here we report two patients harbouring two novel mutations in the G6PC3 gene, including the first Italian patient even described. Both the patients share profound neutropenia with severe infections early in life; in one case non-hematopoietic stigmata of the syndrome, including evident facial dysmorphism and vascular anomalies, appeared gradually over time, prominently in the second decade. Therefore, G6PC3 defects should be considered in any case of congenital, unexplained neutropenia regardless of the clinical phenotype. Both patients are on G-CSF treatment with no evidence of malignant evolution. Even if G6PC3 deficiency seems not to have a propensity towards malignancy, a careful evaluation is warranted.
Appendix
Available only for authorised users
Literature
1.
go back to reference Donadieu J, Fenneteau O, Beaupain B, Mahlaoui N, Bellanné Chantelot C: Congenital neutropenia: diagnosis, molecular bases and patient management.Orphanet J Rare Dis 2011, 6:26., Donadieu J, Fenneteau O, Beaupain B, Mahlaoui N, Bellanné Chantelot C: Congenital neutropenia: diagnosis, molecular bases and patient management.Orphanet J Rare Dis 2011, 6:26.,
2.
go back to reference Botzug K, Klein C: Genetic etiologies of severe congenital neutropenia. Curr Opin Pediatr. 2011, 23 (1): 21-26. 10.1097/MOP.0b013e32834262f8.CrossRef Botzug K, Klein C: Genetic etiologies of severe congenital neutropenia. Curr Opin Pediatr. 2011, 23 (1): 21-26. 10.1097/MOP.0b013e32834262f8.CrossRef
3.
go back to reference Ghosh A, Shieh JJ, Pan CJ, Yang Chou J: Histidine 167 Is the Phospate Acceptor in Glucose-6-phosphate-β Forming a Phosphohistidine Enzyme Intermediate during Catalysis. J Biol Chem. 2004, 279: 12479-12483. 10.1074/jbc.M313271200.CrossRefPubMed Ghosh A, Shieh JJ, Pan CJ, Yang Chou J: Histidine 167 Is the Phospate Acceptor in Glucose-6-phosphate-β Forming a Phosphohistidine Enzyme Intermediate during Catalysis. J Biol Chem. 2004, 279: 12479-12483. 10.1074/jbc.M313271200.CrossRefPubMed
4.
go back to reference Banka S, Newman WG: A clinical and molecular review of ubiquitous glucose-6 phosphatase deficiency caused by G6PC3 mutations.Orphanet J Rare Dis 2013, 8:84., Banka S, Newman WG: A clinical and molecular review of ubiquitous glucose-6 phosphatase deficiency caused by G6PC3 mutations.Orphanet J Rare Dis 2013, 8:84.,
5.
go back to reference Bradley NS, Evans C, Ali A, Ancliff PJ, Hayee B, Segal AW, Hall G, Kaya Z, Shakoori AR, Linch DC, Gale RE: Phenotypic heterogeneity and evidence of a founder effect associated with G6PC3 mutations in patients with severe congenital neutropenia. Br J Haematol. 2012, 158: 138-152. 10.1111/j.1365-2141.2012.09092.x.CrossRef Bradley NS, Evans C, Ali A, Ancliff PJ, Hayee B, Segal AW, Hall G, Kaya Z, Shakoori AR, Linch DC, Gale RE: Phenotypic heterogeneity and evidence of a founder effect associated with G6PC3 mutations in patients with severe congenital neutropenia. Br J Haematol. 2012, 158: 138-152. 10.1111/j.1365-2141.2012.09092.x.CrossRef
6.
go back to reference Botzug K, Appaswamy G, Ashikov A, Schaffer AA, Salzer U, Diestelhorst J, Germeshausen M, Brandes G, Lee-Gossler J, Noyan F, Gatzke AK, Minkov M, Greil J, Kratz C, Petropoulou T, Pellier I, Bellanné-Chantelot C, Rezaei N, Monkemoller K, Irani-Hakimeh N, Hans Bakker H, Gerardy-Schahn R, Zeidler C, Grimbacher B, Welte K, Klein C: A syndrome with Congenital Neutropenia and Mutations in G6PC3. N Engl J Med. 2009, 360: 32-43. 10.1056/NEJMoa0805051.CrossRef Botzug K, Appaswamy G, Ashikov A, Schaffer AA, Salzer U, Diestelhorst J, Germeshausen M, Brandes G, Lee-Gossler J, Noyan F, Gatzke AK, Minkov M, Greil J, Kratz C, Petropoulou T, Pellier I, Bellanné-Chantelot C, Rezaei N, Monkemoller K, Irani-Hakimeh N, Hans Bakker H, Gerardy-Schahn R, Zeidler C, Grimbacher B, Welte K, Klein C: A syndrome with Congenital Neutropenia and Mutations in G6PC3. N Engl J Med. 2009, 360: 32-43. 10.1056/NEJMoa0805051.CrossRef
7.
go back to reference Banka S, Wynn R, Byers H, Arkwright PD, Newman WG: G6PC3 mutations cause non-syndromic severe congenital neutropenia. Mol Genet Metab. 2013, 108: 138-141. 10.1016/j.ymgme.2012.12.001.CrossRefPubMed Banka S, Wynn R, Byers H, Arkwright PD, Newman WG: G6PC3 mutations cause non-syndromic severe congenital neutropenia. Mol Genet Metab. 2013, 108: 138-141. 10.1016/j.ymgme.2012.12.001.CrossRefPubMed
8.
go back to reference Banka S, Newman WG, Ozgul RK, Dursun A: Mutations in the G6PC3 gene cause Dursun syndrome. Am J Med Genet. 2010, 152: 2609-2611. 10.1002/ajmg.a.33615.CrossRef Banka S, Newman WG, Ozgul RK, Dursun A: Mutations in the G6PC3 gene cause Dursun syndrome. Am J Med Genet. 2010, 152: 2609-2611. 10.1002/ajmg.a.33615.CrossRef
9.
go back to reference Dursun A, Ozgul RK, Soydas A, Tugrul T, Gurgey A, Celiker A, Barst RJ, Knowles JA, Mahesh M, Morse JH: Familial pulmonary arterial hypertension, leucopenia, and atrial septal defect: A probable new familial syndrome with multisystem involvement. Clin Dysmorphol. 2009, 18: 19-23. 10.1097/MCD.0b013e32831841f7.CrossRefPubMed Dursun A, Ozgul RK, Soydas A, Tugrul T, Gurgey A, Celiker A, Barst RJ, Knowles JA, Mahesh M, Morse JH: Familial pulmonary arterial hypertension, leucopenia, and atrial septal defect: A probable new familial syndrome with multisystem involvement. Clin Dysmorphol. 2009, 18: 19-23. 10.1097/MCD.0b013e32831841f7.CrossRefPubMed
10.
go back to reference Fackenthal DL, Chen PX, Howe T, Das S: Denaturing high-performance liquid chromatography for mutation detection and genotyping. Methods Mol Biol. 2013, 1015: 25-54. 10.1007/978-1-62703-435-7_2.CrossRefPubMed Fackenthal DL, Chen PX, Howe T, Das S: Denaturing high-performance liquid chromatography for mutation detection and genotyping. Methods Mol Biol. 2013, 1015: 25-54. 10.1007/978-1-62703-435-7_2.CrossRefPubMed
11.
go back to reference Botzug K, Rosenberg PS, Dorda M, Banka S, Moulton T, Curtin J, Rezaei N, Corns J, Innis JW, Avci Z, Chi Tran H, Pellier I, Pierani P, Fruge R, Parvaneh N, Mamishi S, Mody R, Darbyshire P, Motwani J, Murray J, Buchanan GR, Newman WG, Alter BP, Boxer LA, Donadieu J, Welte K, Klein C: Extended Spectrum of Human Glucose-6-Phosphatase Catalytic Subunit 3 Deficiency: novel Genotypes and Phenotypic Variability in Severe Congenital Neutropenia. J Pediatr. 2011, 160: 679-683. Botzug K, Rosenberg PS, Dorda M, Banka S, Moulton T, Curtin J, Rezaei N, Corns J, Innis JW, Avci Z, Chi Tran H, Pellier I, Pierani P, Fruge R, Parvaneh N, Mamishi S, Mody R, Darbyshire P, Motwani J, Murray J, Buchanan GR, Newman WG, Alter BP, Boxer LA, Donadieu J, Welte K, Klein C: Extended Spectrum of Human Glucose-6-Phosphatase Catalytic Subunit 3 Deficiency: novel Genotypes and Phenotypic Variability in Severe Congenital Neutropenia. J Pediatr. 2011, 160: 679-683.
12.
go back to reference Lin JH, Walter P, Yen TS: Endoplasmic reticulum stress in disease pathogenesis. Annu Rev Pathol. 2008, 3: 399-425. 10.1146/annurev.pathmechdis.3.121806.151434.PubMedCentralCrossRefPubMed Lin JH, Walter P, Yen TS: Endoplasmic reticulum stress in disease pathogenesis. Annu Rev Pathol. 2008, 3: 399-425. 10.1146/annurev.pathmechdis.3.121806.151434.PubMedCentralCrossRefPubMed
13.
go back to reference Mc Dermott DH, De Ravin SS, Sik Jun H, Liu Q, Long Priel DA, Noel P, Takemoto CM, Ojode T, Paul SM, Dunsmore KP, Hilligoss D, Marquesen M, Ulrick J, Kuhns DB, Chou JY, Malech HL, Murphy PM: Severe congenital neutropenia resulting from G6PC3 deficiency with increased neutrophil CXCR4 expression and myelokathexis. Blood. 2010, 116: 2793-2802. 10.1182/blood-2010-01-265942.CrossRef Mc Dermott DH, De Ravin SS, Sik Jun H, Liu Q, Long Priel DA, Noel P, Takemoto CM, Ojode T, Paul SM, Dunsmore KP, Hilligoss D, Marquesen M, Ulrick J, Kuhns DB, Chou JY, Malech HL, Murphy PM: Severe congenital neutropenia resulting from G6PC3 deficiency with increased neutrophil CXCR4 expression and myelokathexis. Blood. 2010, 116: 2793-2802. 10.1182/blood-2010-01-265942.CrossRef
14.
go back to reference Banka S, Wynn R, Newman WG: Variability of bone marrow morphology in G6PC3 mutations: Is there a genotype-phenotype correlation or age dependent relationship?. Am J Hematol. 2011, 86 (2): 235-237. 10.1002/ajh.21930.CrossRefPubMed Banka S, Wynn R, Newman WG: Variability of bone marrow morphology in G6PC3 mutations: Is there a genotype-phenotype correlation or age dependent relationship?. Am J Hematol. 2011, 86 (2): 235-237. 10.1002/ajh.21930.CrossRefPubMed
15.
go back to reference Banka S, Chervinsky E, Newman WG, Crow YJ, Yeganeh S, Yacobovich J, Donnai D, Shalev S: Further delineation of the phenotype of severe congenital neutropenia type 4 due to mutations in G6PC3. Eur J Hum Genet. 2011, 19: 18-22. 10.1038/ejhg.2010.136.PubMedCentralCrossRefPubMed Banka S, Chervinsky E, Newman WG, Crow YJ, Yeganeh S, Yacobovich J, Donnai D, Shalev S: Further delineation of the phenotype of severe congenital neutropenia type 4 due to mutations in G6PC3. Eur J Hum Genet. 2011, 19: 18-22. 10.1038/ejhg.2010.136.PubMedCentralCrossRefPubMed
16.
go back to reference Germeshausen M, Zeidler C, Stuhrmann M, Lanciotti M, Ballmaier M, Welte K: Digenic mutations in severe congenital neutropenia. Haematologica. 2010, 95: 1207-1210. 10.3324/haematol.2009.017665.PubMedCentralCrossRefPubMed Germeshausen M, Zeidler C, Stuhrmann M, Lanciotti M, Ballmaier M, Welte K: Digenic mutations in severe congenital neutropenia. Haematologica. 2010, 95: 1207-1210. 10.3324/haematol.2009.017665.PubMedCentralCrossRefPubMed
17.
go back to reference Yeshayahu Y, Asaf R, Dubnov-Raz G, Schiby G, Simon AJ, Lev A, Somech R: Testicular failure in a patient with G6PC3 deficiency.Pediatr Res 2014. doi:10.1038/pr.2014.64., Yeshayahu Y, Asaf R, Dubnov-Raz G, Schiby G, Simon AJ, Lev A, Somech R: Testicular failure in a patient with G6PC3 deficiency.Pediatr Res 2014. doi:10.1038/pr.2014.64.,
18.
go back to reference Bonilla MA, Gillio AP, Ruggeiro M, Kernan NA, Brochstein JA, Abboud M, Fumagalli L, Vincent M, Gabrilove JL, Welte K, Souza LM, O'Reilly RJ: Effects of recombinant human granulocyte colony-stimulating factor on neutropenia in patients with congenital agranulocytosis. N Engl J Med. 1989, 320: 1574-1580. 10.1056/NEJM198906153202402.CrossRefPubMed Bonilla MA, Gillio AP, Ruggeiro M, Kernan NA, Brochstein JA, Abboud M, Fumagalli L, Vincent M, Gabrilove JL, Welte K, Souza LM, O'Reilly RJ: Effects of recombinant human granulocyte colony-stimulating factor on neutropenia in patients with congenital agranulocytosis. N Engl J Med. 1989, 320: 1574-1580. 10.1056/NEJM198906153202402.CrossRefPubMed
19.
go back to reference Dale DC, Bonilla MA, Davis MW, Nakanishi AM, Hammond WP, Kurtzberg J, Wang W, Jakubowski A, Winton E, Lalezari P: A randomized controlled phase III trial of recombinant human granulocyte colony-stimulating factor (filgrastim) for treatment of severe chronic neutropenia. Blood. 1993, 81: 2496-2502.PubMedCentralPubMed Dale DC, Bonilla MA, Davis MW, Nakanishi AM, Hammond WP, Kurtzberg J, Wang W, Jakubowski A, Winton E, Lalezari P: A randomized controlled phase III trial of recombinant human granulocyte colony-stimulating factor (filgrastim) for treatment of severe chronic neutropenia. Blood. 1993, 81: 2496-2502.PubMedCentralPubMed
20.
go back to reference Donadieu J, Leblanc T, Bade Meunier B, Barkaoui M, Fenneteau O, Bertrand Y, Maier-Redelsperger M, Micheau M, Stephan JL, Phillipe N, Bordigoni P, Babin-Boilletot A, Bensaid P, Manel AM, Vilmer E, Thuret I, Blanche S, Gluckman E, Fischer A, Mechinaud F, Joly B, Lamy T, Hermine O, Cassinat B, Bellanné-Chantelot C: Analysis of risk factors for myelodysplasias, leukemias and death from infection among patients with congenital neutropenia. Experience of the French Severe Chronic Neutropenia Study Group. Haematologica. 2005, 90: 45-53.PubMed Donadieu J, Leblanc T, Bade Meunier B, Barkaoui M, Fenneteau O, Bertrand Y, Maier-Redelsperger M, Micheau M, Stephan JL, Phillipe N, Bordigoni P, Babin-Boilletot A, Bensaid P, Manel AM, Vilmer E, Thuret I, Blanche S, Gluckman E, Fischer A, Mechinaud F, Joly B, Lamy T, Hermine O, Cassinat B, Bellanné-Chantelot C: Analysis of risk factors for myelodysplasias, leukemias and death from infection among patients with congenital neutropenia. Experience of the French Severe Chronic Neutropenia Study Group. Haematologica. 2005, 90: 45-53.PubMed
Metadata
Title
Severe congenital neutropenia due to G6PC3 deficiency: early and delayed phenotype in two patients with two novel mutations
Authors
Lucia Dora Notarangelo
Gianfranco Savoldi
Sara Cavagnini
Veronica Bennato
Sabrina Vasile
Alba Pilotta
Alessandro Plebani
Fulvio Porta
Publication date
01-12-2014
Publisher
BioMed Central
Published in
Italian Journal of Pediatrics / Issue 1/2014
Electronic ISSN: 1824-7288
DOI
https://doi.org/10.1186/s13052-014-0080-8

Other articles of this Issue 1/2014

Italian Journal of Pediatrics 1/2014 Go to the issue